These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 18551280

  • 1. Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15.
    Kiss B, Laszlovszky I, Horváth A, Némethy Z, Schmidt E, Bugovics G, Fazekas K, Gyertyán I, Agai-Csongor E, Domány G, Szombathelyi Z.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):515-28. PubMed ID: 18551280
    [Abstract] [Full Text] [Related]

  • 2. Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15.
    Gyertyán I, Sághy K, Laszy J, Elekes O, Kedves R, Gémesi LI, Pásztor G, Zájer-Balázs M, Kapás M, Agai Csongor E, Domány G, Kiss B, Szombathelyi Z.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):529-39. PubMed ID: 18548231
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [Abstract] [Full Text] [Related]

  • 4. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg, Mikaels, Mohell N.
    J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
    [Abstract] [Full Text] [Related]

  • 5. Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats.
    Kosmowska B, Wardas J, Głowacka U, Ananthan S, Ossowska K.
    CNS Neurosci Ther; 2016 Jan; 22(1):53-62. PubMed ID: 26459182
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
    Roberts C, Cummins R, Gnoffo Z, Kew JN.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):108-14. PubMed ID: 16490190
    [Abstract] [Full Text] [Related]

  • 7. Preclinical Evaluation of the Effects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D2/D3 Receptor Antagonist for the Management of Gastroparesis.
    Whiting RL, Choppin A, Luehr G, Jasper JR.
    J Pharmacol Exp Ther; 2021 Oct 18; 379(1):85-95. PubMed ID: 34253646
    [Abstract] [Full Text] [Related]

  • 8. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
    Gyertyán I, Sághy K.
    Behav Pharmacol; 2004 Jul 18; 15(4):253-62. PubMed ID: 15252275
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.
    Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY, Boyfield I, Branch CL, Cilia J, Coldwell MC, Hadley MS, Hunter AJ, Jeffrey P, Jewitt F, Johnson CN, Jones DN, Medhurst AD, Middlemiss DN, Nash DJ, Riley GJ, Routledge C, Stemp G, Thewlis KM, Trail B, Vong AK, Hagan JJ.
    J Pharmacol Exp Ther; 2000 Sep 18; 294(3):1154-65. PubMed ID: 10945872
    [Abstract] [Full Text] [Related]

  • 10. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A, Rivet JM, Audinot V, Cistarelli L, Spedding M, Vian J, Peglion JL, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 18; 275(2):899-913. PubMed ID: 7473181
    [Abstract] [Full Text] [Related]

  • 11. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.
    Kiss B, Horváth A, Némethy Z, Schmidt E, Laszlovszky I, Bugovics G, Fazekas K, Hornok K, Orosz S, Gyertyán I, Agai-Csongor E, Domány G, Tihanyi K, Adham N, Szombathelyi Z.
    J Pharmacol Exp Ther; 2010 Apr 18; 333(1):328-40. PubMed ID: 20093397
    [Abstract] [Full Text] [Related]

  • 12. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 18; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 13. Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.
    Millan MJ, Rivet JM, Audinot V, Gobert A, Lejeune F, Brocco M, Newman-Tancredi A, Maurel-Remy S, Bervoets K.
    J Pharmacol Exp Ther; 1995 Jun 18; 273(3):1418-27. PubMed ID: 7791116
    [Abstract] [Full Text] [Related]

  • 14. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K, Tada S, Matsumoto M, Ohmori J, Tasaki Y, Nomura T, Usuda S, Yamaguchi T.
    Br J Pharmacol; 1996 Apr 18; 117(8):1625-32. PubMed ID: 8732269
    [Abstract] [Full Text] [Related]

  • 15. Examining dopamine D3 receptor occupancy by antipsychotic drugs via [3H]7-OH-DPAT ex vivo autoradiography and its cross-validation via c-fos immunohistochemistry in the rat brain.
    Davoodi N, te Riele P, Langlois X.
    Eur J Pharmacol; 2014 Oct 05; 740():669-75. PubMed ID: 24967534
    [Abstract] [Full Text] [Related]

  • 16. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 05; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 17. Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine.
    Kiss B, Némethy Z, Fazekas K, Kurkó D, Gyertyán I, Sághy K, Laszlovszky I, Farkas B, Kirschner N, Bolf-Terjéki E, Balázs O, Lendvai B.
    Drug Des Devel Ther; 2019 Jan 05; 13():3229-3248. PubMed ID: 31571826
    [Abstract] [Full Text] [Related]

  • 18. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.
    Millan MJ, Peglion JL, Vian J, Rivet JM, Brocco M, Gobert A, Newman-Tancredi A, Dacquet C, Bervoets K, Girardon S.
    J Pharmacol Exp Ther; 1995 Nov 05; 275(2):885-98. PubMed ID: 7473180
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110.
    Park WK, Jeong D, Yun CW, Lee S, Cho H, Kim GD, Koh HY, Pae AN, Cho YS, Choi KI, Jung JY, Jung SH, Kong JY.
    Pharmacol Res; 2003 Dec 05; 48(6):615-22. PubMed ID: 14527827
    [Abstract] [Full Text] [Related]

  • 20. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ, Mannoury la Cour C, Novi F, Maggio R, Audinot V, Newman-Tancredi A, Cussac D, Pasteau V, Boutin JA, Dubuffet T, Lavielle G.
    J Pharmacol Exp Ther; 2008 Feb 05; 324(2):587-99. PubMed ID: 18024789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.